Get the app!
Back to Trades
Other4

Keros Therapeutics, Inc.

KROS

Total Value
$3.8M

Company Information

Ticker Symbol
KROS
CIK
0001664710

Insider Information

Role
Director
Location
LEXINGTON, MA

Filing Details

Filing Date
Dec 18, 2025
Transaction Date
Nov 21, 2025
Accession Number
0000947871-25-001084
Form Type
4

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.